**Summary 1: "What Washington wants in Cures 2.0"**

Reps. Diana DeGette and Larry Bucshon are advancing "Cures 2.0," legislation building on the 2016 21st Century Cures Act, aimed to enhance health data sharing, FDA approval processes, and research. The follow-up aims to address pandemic prevention and better data governance, with industry lobbyists suggesting specific improvements in these areas. Organizations such as AHIP, the American Health Information Management Association, and others provided feedback emphasizing the importance of unlocking health data to improve outcomes and reduce costs.

**Summary 2: "NO BUPE RX UPTICK"**

Relaxing the X-waiver requirements, which once restricted the prescription of buprenorphine for opioid use disorder, did not significantly increase the number of prescriptions or patient access as intended. Although more clinicians were qualified to prescribe the drug post-2021 policy change, the actual prescription rates and patient uptake saw minimal impact, with notable increases only in select communities in Kentucky and Massachusetts. This suggests that waiving the X-waiver alone may not be sufficient to broaden access to buprenorphine treatment.

**Summary 3: "RECORD HEALTH CENTER PAT

What Washington wants in Cures 2.0 publication

**Summary: Erosion of Trust in Health Care: A Public Health Crisis**

A recent study published in JAMA Network Open highlights a significant decrease in trust towards physicians and hospital systems across the U.S. from the onset of the COVID-19 pandemic through January 2024. Conducted through 24 waves of surveys involving 443,455 adults, the data showed a 31.4 percentage point drop in trust, consistent across various demographics. This distrust has been correlated with lower rates of COVID-19 vaccination and poses a challenge to public health efforts. The study underscores the urgent need to restore trust in healthcare to improve compliance with health measures and outcomes, despite challenges in addressing this complex issue.

**Summary: Cross-Validation of Insurer and Hospital Price Transparency Data**

A study comparing price transparency data from insurers and hospitals in Mississippi revealed a low overlap but high concordance in pricing. Out of 2,000+ hospital-billing code observations, only 16.3% were present in both data sources. However, overlapping prices showed a high correlation, with 77.4% matching exactly and 84.4% within a 10% margin. This indicates accurate pricing despite administrative misalignment. The study emphasizes the need to simplify

Erosion of Trust in Health Care: A Public Health Crisis publication

This week's health innovation funding highlights include significant investments across various sectors. Flo Health, a fertility-focused period-tracking app, raised $200M from General Atlantic. Mental health saw Spring Health secure $100M, while AI-driven drug discovery company Healx raised $47M. Dental AI startup Perceptive received $30M, and MedScout, focusing on commercial operations for medtech, raised $15M. Other notable funding includes Guidehealth's $14M for value-based care, and Noze's $5M for breath-based diagnostics. Additionally, an Alzheimer’s innovation initiative was launched to foster collaborative progress in the disease's prevention, diagnosis, and management.

Big Bets as Health Tech Funding Heats Up | StartUp Health Insights: Week of Aug 6, 2024 — StartUp Health StartUp Health

In the article "Here's why Apple will become the world’s leading AI vendor," Jonny Evans argues that Apple is poised to dominate the AI ecosystem by leveraging its powerful Apple Silicon processors and an integrated platform that spans mobile, PC, and cloud. With upcoming device releases featuring the advanced M4 chips, Apple aims to enhance personal productivity and develop AI-specific features across its ecosystem. The company's unique approach to user privacy and extensive user base could allow it to quickly gain market traction, positioning Apple's AI capabilities as a significant innovation in a competitive landscape.

Here’s why Apple will become the world’s leading AI vendor Computerworld